Market share and costs of biologic therapies for inflammatory bowel disease in the USA.
Yu, H; MacIsaac, D; Wong, J J; Sellers, Z M; Wren, A A; Bensen, R; Kin, C; Park, K T.
Aliment Pharmacol Ther
; 47(3): 364-370, 2018 02.
Artigo em Inglês | MEDLINE | ID: mdl-29164650
Entrepreneurship in Nursing: overview of companies in the State of São Paulo.
Tuberculosis treatment in the private healthcare sector in India: an analysis of recent trends and volumes using drug sales data.
Market Concentration and Potential Competition in Medicare Advantage.
Interventions to reduce corruption in the health sector.
Economic and non-economic determinants of Iranian pharmaceutical companies' financial performance: an empirical study.
Is health care infected by Baumol's cost disease? Test of a new model.
A decade of aid coordination in post-conflict Burundi's health sector.
Regional Interrelationships: A Leadership Opportunity for Health Care.
Testing times: trends in availability, price, and market share of malaria diagnostics in the public and private healthcare sector across eight sub-Saharan African countries from 2009 to 2015.
Transformation of the Health Care Industry: Curb Your Enthusiasm?